Cocaine Abuse

Dr. Higgins has received numerous scientific awards, is President-elect of the Division of Psychopharmacology and Substance Use of the American Psychological Association, is Principal and Co-Investigator on numerous federal research grants, and publishes extensively on cocaine abuse in the scientific literature. He earned his Ph.D. from the University of Kansas in 1983. He was a post-doctoral fellow at the Johns Hopkins University School of Medicine from 1983-1984. From 1985-1986, Dr. Higgins was a staff fellow at the Addiction Research Center of the National Institute of Drug Abuse in Baltimore, Maryland. In 1986, he joined the faculty of the University of Vermont where he is now Professor of Psychiatry and Psychology. His research is a blend of laboratory and treatment-outcome research, primarily focused on developing effective treatments for cocaine abuse. Dr. Jonathan L. Katz received his Ph.D. in Psychology at the University of Maryland in 1973. He received fellowships from the National Institute of Mental Health and the National Institute on Drug Abuse. He obtained postgraduate training in the Laboratory of Psychobiology at the Harvard Medical School. Following that training he was on the research faculty of the Department of Pharmacology at the University of Michigan Medical School from 1980 to 1982. The next year he took a position in the Intramural Research Program of the National Institute on Drug Abuse, where he serves as Chief of the Psychobiology Section. In addition, Dr. Katz holds the position of Adjunct Associate Professor in the Department of Pharmacology and Experimental Therapeutics at the University of Maryland School of Medicine. Dr. Katz engages in public and professional service through several professional societies and government agencies, and has published extensively in the scientific literature.

P.B. Dews, Forward.
S.T. Higgins and J.L. Katz, Preface.
S. Izenwasser, Basic Pharmacological Mechanisms of Cocaine.
S.B. Caine, Neuroanatomical Bases of the Reinforcing Stimulus Effects of Cocaine.
J. Bergman and J.L. Katz, Behavioral Pharmacology of Cocaine and the Determinants of Abuse Liability.
M.E. Carroll and W.K. Bickel, Behavioral-Environmental Determinants of the Reinforcing Functions of Cocaine.
W.L. Woolverton and S.R.B. Weiss, Tolerance and Sensitization to Cocaine: An Integrated View.
G. Winger, Preclinical Evaluation of Pharmacotherapies for Cocaine Abuse.
K.F. Schama, L.L. Howell, and L.D. Byrd, Prenatal Exposure to Cocaine.
M.W. Fischman and R.W. Foltin, Cocaine Self-Administration Research: Implications for Rational Pharmacotherapy.
G.E. Bigelow and S.L. Walsh, Evaluation of Potential Pharmacotherapies: Response to Cocaine Challenge in the Human Laboratory.
C.R. Rush, J.M. Roll, and S.T. Higgins Controlled Laboratory Studies on the Effects of Cocaine in Combination with Other Commonly Abused Drugs in Humans.
S.E. Lukas and P.F. Renshaw, Cocaine Effects on Brain Function.
G.I. Elmer, L.L. Miner, and R.W. Pickens, The Contribution of Genetic Factors in Cocaine and Other Drug Abuse.
H.D. Chilcoat and C-E. Johanson, Vulnerability to Cocaine Abuse.
S.T. Higgins and C.J. Wong, Treating Cocaine Abuse: What Does Research Tell Us?
K. Silverman, G.E. Bigelow, and M.L. Stitzer, Treatment of Cocaine Abuse in Methadone Maintenance Patients.
S.M. Hall, D.A. Wasserman, B.E. Havassy, and P. Maude-Griffin Relapse to Cocaine Use.
T.J. Crowley and J.T. Brewster, Cocaine Legalization: Designing the Experiments.
Index.